Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine
It was reported on July 24 that Sanofi (NASDAQ:SNY) shares underperformed in European trading following the company’s decision…
Browsing Tag